Dowling & Yahnke’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.69M | Buy |
9,546
+28
| +0.3% | +$5.53K | 0.08% | 190 |
|
|
2022
Q2 | $1.95M | Sell |
9,518
-60
| -0.6% | -$12.7K | 0.09% | 176 |
|
|
2022
Q1 | $2.28M | Buy |
9,578
+1,152
| +14% | +$271K | 0.1% | 169 |
|
|
2021
Q4 | $1.93M | Buy |
8,426
+80
| +1% | +$17.6K | 0.09% | 174 |
|
|
2021
Q3 | $1.61M | Buy |
8,346
+363
| +5% | +$73.5K | 0.09% | 184 |
|
|
2021
Q2 | $1.7M | Buy |
7,983
+516
| +7% | +$109K | 0.1% | 173 |
|
|
2021
Q1 | $1.52M | Buy |
7,467
+137
| +2% | +$27K | 0.1% | 171 |
|
|
2020
Q4 | $1.33M | Sell |
7,330
-227
| -3% | -$38.6K | 0.1% | 176 |
|
|
2020
Q3 | $1.26M | Sell |
7,557
-527
| -7% | -$88.8K | 0.1% | 169 |
|
|
2020
Q2 | $1.31M | Sell |
8,084
-482
| -6% | -$86.4K | 0.11% | 172 |
|
|
2020
Q1 | $1.48M | Buy |
8,566
+287
| +3% | +$57.1K | 0.14% | 151 |
|
|
2019
Q4 | $1.66M | Sell |
8,279
-195
| -2% | -$40K | 0.13% | 159 |
|
|
2019
Q3 | $1.79M | Sell |
8,474
-1
| -0% | -$209 | 0.15% | 151 |
|
|
2019
Q2 | $1.65M | Buy |
8,475
+15
| +0.2% | +$2.77K | 0.14% | 159 |
|
|
2019
Q1 | $1.39M | Buy |
8,460
+348
| +4% | +$61.5K | 0.13% | 148 |
|
|
2018
Q4 | $1.54M | Buy |
8,112
+5
| +0.1% | +$923 | 0.16% | 138 |
|
|
2018
Q3 | $1.38M | Sell |
8,107
-80
| -1% | -$13.5K | 0.12% | 175 |
|
|
2018
Q2 | $1.34M | Buy |
8,187
+525
| +7% | +$85.7K | 0.12% | 172 |
|
|
2018
Q1 | $1.24M | Buy |
7,662
+230
| +3% | +$36.6K | 0.12% | 174 |
|
|
2017
Q4 | $1.08M | Buy |
7,432
+260
| +4% | +$37K | 0.1% | 186 |
|
|
2017
Q3 | $973K | Buy |
7,172
+133
| +2% | +$16.8K | 0.1% | 182 |
|
|
2017
Q2 | $882K | Buy |
7,039
+195
| +3% | +$23.3K | 0.09% | 185 |
|
|
2017
Q1 | $813K | Buy |
6,844
+114
| +2% | +$13.7K | 0.09% | 192 |
|
|
2016
Q4 | $776K | Buy |
6,730
+165
| +3% | +$18.4K | 0.09% | 185 |
|
|
2016
Q3 | $686K | Buy |
6,565
+170
| +3% | +$17.7K | 0.08% | 187 |
|
|
2016
Q2 | $623K | Buy |
6,395
+417
| +7% | +$39.4K | 0.07% | 185 |
|
|
2016
Q1 | $574K | Buy |
5,978
+94
| +2% | +$8.55K | 0.07% | 189 |
|
|
2015
Q4 | $533K | Sell |
5,884
-357
| -6% | -$33.6K | 0.07% | 193 |
|
|
2015
Q3 | $579K | Buy |
6,241
+807
| +15% | +$76.7K | 0.08% | 183 |
|
|
2015
Q2 | $506K | Buy |
5,434
+445
| +9% | +$41.5K | 0.06% | 197 |
|
|
2015
Q1 | $473K | Sell |
4,989
-140
| -3% | -$13K | 0.06% | 200 |
|
|
2014
Q4 | $455K | Buy |
5,129
+170
| +3% | +$14.4K | 0.06% | 201 |
|
|
2014
Q3 | $396K | Sell |
4,959
-425
| -8% | -$32K | 0.05% | 199 |
|
|
2014
Q2 | $382K | Sell |
5,384
-950
| -15% | -$66.9K | 0.05% | 215 |
|
|
2014
Q1 | $469K | Sell |
6,334
-25
| -0.4% | -$1.89K | 0.06% | 200 |
|
|
2013
Q4 | $499K | Buy |
6,359
+50
| +0.8% | +$3.92K | 0.07% | 187 |
|
|
2013
Q3 | $466K | Sell |
6,309
-60
| -0.9% | -$4.42K | 0.07% | 183 |
|
|
2013
Q2 | $484K | Buy |
+6,369
| New | +$418K | 0.08% | 173 |
|
Other funds holding CME
Dowling & Yahnke's CME Position: Q3 2022 in Review
Dowling & Yahnke increased its CME Group (CME) stake by 0.29% in Q3 2022, buying an estimated $5.53K and bringing the position to 9,546 shares worth $1.69M. The position accounts for 0.08% of the portfolio, ranked #190.
Dowling & Yahnke first reported a position in CME in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.28M in Q1 2022. 1,144 funds tracked by Wall St. Rank hold CME as of Q3 2022.
- Dowling & Yahnke held 9,546 shares of CME Group worth $1.69M as of Q3 2022.
- Dowling & Yahnke bought 28 CME Group shares in Q3 2022, an estimated $5.53K.
- CME Group made up 0.08% of Dowling & Yahnke's portfolio in Q3 2022, its #190 holding.
- Dowling & Yahnke first reported a position in CME Group in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's CME Group position peaked at $2.28M in Q1 2022.
- 1,144 funds tracked by Wall St. Rank held CME Group as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.